Latest disclosed trades
Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.
See the tradesUpdated Oct 17 · 1 feed behind: Insider filings, 3 days · Every feed →
ARTV · Insiders · $100K+ · 89 trades
Trades
89
Buys 84 · Sells 5
People
8
Stocks
1
Disclosed value
$106M
range midpoints · Congress & executive
Filed late
0
- ▼ SELLFred Aslan Chief Executive OfficerARTV Artiva Biotherapeutics, Inc.$169Kdisclosed Oct 7 · filed 1 day after the trade
- ▼ SELLFred Aslan Chief Executive OfficerARTV Artiva Biotherapeutics, Inc.$422Kdisclosed Oct 6 · filed 1 day after the trade
- ▼ SELLFred Aslan Chief Executive OfficerARTV Artiva Biotherapeutics, Inc.$256Kdisclosed Sep 9 · filed 1 day after the trade
- ▼ SELLFred Aslan Chief Executive OfficerARTV Artiva Biotherapeutics, Inc.$690Kdisclosed Sep 4 · filed 1 day after the trade
- ▼ SELLChristopher Horan Chief Tech Operations OfficerARTV Artiva Biotherapeutics, Inc.$116Kdisclosed Sep 4 · filed 1 day after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$248Kdisclosed Jul 31 · filed the same day
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$208Kdisclosed Jul 31 · filed 2 days after the trade
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.2Mdisclosed Jul 23 · filed 2 days after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$835Kdisclosed Jul 23 · filed 1 day after the trade